Class I anti-arrhythmic

0 marketed 1 in Phase 1

This page covers all Class I anti-arrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium channels.

Targets

Potassium channels

Phase 1 pipeline (1)

Patent intelligence